Gene · 965
Papers4,043
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 4,043
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Case report: Successful management of a refractory double-expressor diffuse large B-cell lymphoma patient under the guidance of in vitro high-throughput drug sensitivity test. | Front Oncol | 2022 | 36741708 | PubTator, text mining | PubMed |
| Chemokine-like factor-like MARVEL transmembrane domain containing 6: Bioinformatics and experiments in vitro analyze in glioblastoma multiforme. | Front Mol Neurosci | 2022 | 36698778 | PubTator, text mining | PubMed |
| Identification of Two Novel Linear B Cell Epitopes on the CD2v Protein of African Swine Fever Virus Using Monoclonal Antibodies. | Viruses | 2022 | 36680174 | PubTator, text mining | PubMed |
| Extracellular Vesicle Membrane Protein Profiling and Targeted Mass Spectrometry Unveil CD59 and Tetraspanin 9 as Novel Plasma Biomarkers for Detection of Colorectal Cancer. | Cancers (Basel) | 2022 | 36612172 | PubTator, text mining | PubMed |
| The Cytokine Network in Colorectal Cancer: Implications for New Treatment Strategies. | Cells | 2022 | 36611932 | PubTator, text mining | PubMed |
| Immunophenotype of Measurable Residual Blast Cells as an Additional Prognostic Factor in Adults with B-Cell Acute Lymphoblastic Leukemia. | Diagnostics (Basel) | 2022 | 36611312 | PubTator, text mining | PubMed |
| Exosomal long non-coding RNAs: novel molecules in gastrointestinal cancers' progression and diagnosis. | Front Oncol | 2022 | 36591473 | PubTator, text mining | PubMed |
| The role of erythrocytes and erythroid progenitor cells in tumors. | Open Life Sci | 2022 | 36567722 | PubTator, text mining | PubMed |
| Identifying the Role of Oxidative Stress-Related Genes as Prognostic Biomarkers and Predicting the Response of Immunotherapy and Chemotherapy in Ovarian Cancer. | Oxid Med Cell Longev | 2022 | 36561981 | PubTator, text mining | PubMed |
| Genetic engineering of pigs for xenotransplantation to overcome immune rejection and physiological incompatibilities: The first clinical steps. | Front Immunol | 2022 | 36561750 | PubTator, text mining | PubMed |
| Types of T-cell lymphoma-a cytogenetic perspective. | Ann Med Surg (Lond) | 2022 | 36536747 | PubTator, text mining | PubMed |
| Identifying differentially expressed genes and miRNAs in Kawasaki disease by bioinformatics analysis. | Sci Rep | 2022 | 36536067 | PubTator, text mining | PubMed |
| The Yin-Yang of myeloid cells in the leukemic microenvironment: Immunological role and clinical implications. | Front Immunol | 2022 | 36532078 | PubTator, text mining | PubMed |
| STXBP3 and GOT2 predict immunological activity in acute allograft rejection. | Front Immunol | 2022 | 36532048 | PubTator, text mining | PubMed |
| PAX5 epigenetically orchestrates CD58 transcription and modulates blinatumomab response in acute lymphoblastic leukemia. | Sci Adv | 2022 | 36516256 | PubTator, text mining | PubMed |
| Promising drugs and treatment options for pediatric and adolescent patients with Hodgkin lymphoma. | Front Cell Dev Biol | 2022 | 36506094 | PubTator, text mining | PubMed |
| Natural Killer Cells in Chronic Lymphocytic Leukemia: Functional Impairment and Therapeutic Potential. | Cancers (Basel) | 2022 | 36497266 | PubTator, text mining | PubMed |
| Dying of Stress: Chemotherapy, Radiotherapy, and Small-Molecule Inhibitors in Immunogenic Cell Death and Immunogenic Modulation. | Cells | 2022 | 36497086 | PubTator, text mining | PubMed |
| Commercial DURAClone panels for extending the repertoire of multicolour immunophenotypic panels in an academic flow cytometry laboratory in South Africa. | Afr J Lab Med | 2022 | 36483322 | PubTator, text mining | PubMed |
| Identification of subtypes of hepatocellular carcinoma and screening of prognostic molecular diagnostic markers based on cell adhesion molecule related genes. | Front Genet | 2022 | 36482887 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/965/papers?page=23